During the practice of midwifery a licensed midwife may obtain and administer the following drugs described in the midwifery formula, according to the protocol outlined in Appendix A, describing the indication for use, dosage, route of administration and duration of treatment:
(a) Oxygen;
(b) Oxytocin as a postpartum antihemorrhagic agent;
(c) Misoprostol as a postpartum antihemorrhagic agent;
(d) Methylergonovine (Methergine) as a postpartum antihemorrhagic agent;
(e) Injectable local anesthetic for the repair of lacerations which are no more extensive than second degree;
(f) Antibiotics for group B streptococcus prophylaxis consistent with the guidelines set forth in Prevention of Perinatal Group B Streptococcal Disease, published by the Centers for Disease Control and Prevention and for prolonged rupture of membranes;
(g) Epinephrine administered via a metered dose auto-injector;
(h) Intravenous fluids for stabilization of the woman;
(i) Rho(D) immune globulin;
(j) Phylloquinone (Vitamin K1);
(k) Eye prophylactics for the baby;
(l) Sterile H2O Papules; and
(m) Terbutaline.
036-7 Wyo. Code R. § 7-5
Amended, Eff. 12/10/2015.
Amended, Eff. 7/18/2018.